MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 280 filers reported holding MYRIAD GENETICS INC in Q3 2014. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $622,000 | -31.6% | 18,300 | -28.8% | 0.00% | 0.0% |
Q1 2015 | $910,000 | -44.9% | 25,700 | -47.0% | 0.00% | 0.0% |
Q4 2014 | $1,652,000 | +1.5% | 48,500 | +14.9% | 0.00% | 0.0% |
Q3 2014 | $1,628,000 | +442.7% | 42,200 | +448.1% | 0.00% | – |
Q2 2014 | $300,000 | +6.8% | 7,700 | -42.5% | 0.00% | – |
Q4 2013 | $281,000 | -37.1% | 13,400 | -29.5% | 0.00% | – |
Q3 2013 | $447,000 | -12.5% | 19,000 | 0.0% | 0.00% | -100.0% |
Q2 2013 | $511,000 | – | 19,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 250,000 | $5,875,000 | 2.93% |
MUHLENKAMP & CO INC | 484,765 | $11,392,000 | 2.26% |
KESTREL INVESTMENT MANAGEMENT CORP | 854,475 | $20,080,000 | 2.06% |
TEALWOOD ASSET MANAGEMENT INC | 154,975 | $3,642,000 | 1.61% |
NEW AMSTERDAM PARTNERS LLC/NY | 1,958,356 | $46,022,000 | 1.54% |
S&T BANK/PA | 398,578 | $9,367,000 | 1.46% |
MAZAMA CAPITAL MANAGEMENT INC | 87,580 | $2,058,000 | 1.12% |
RA Capital Management | 450,000 | $10,575,000 | 1.10% |
Palisades Investment Partners, LLC | 48,100 | $1,130,000 | 1.06% |
TIVERTON ASSET MANAGEMENT LLC | 1,780,200 | $41,836,000 | 1.01% |